IPC분류정보
| 국가/구분 |
United States(US) Patent
등록
|
| 국제특허분류(IPC7판) |
|
| 출원번호 |
US-0589381
(2000-06-07)
|
|
발명자
/ 주소 |
- Bronshtein, Victor
- Bracken, Kevin R.
- Livers, Ronnie K.
- Williams, David R.
|
| 출원인 / 주소 |
- Quadrant Drug Delivery Limited
|
| 대리인 / 주소 |
Knobbe, Martens, Olson & Bear, LLP
|
| 인용정보 |
피인용 횟수 :
22 인용 특허 :
8 |
초록
▼
This invention relates to barrier methods for preserving sensitive biological materials as a porous foam, subsequently crushing the foam to form a powder, and optionally formulating mixtures of preserved powdered biological materials. The invention also encompasses an apparatus for integrating the m
This invention relates to barrier methods for preserving sensitive biological materials as a porous foam, subsequently crushing the foam to form a powder, and optionally formulating mixtures of preserved powdered biological materials. The invention also encompasses an apparatus for integrating the methods of foam formation and subsequent crushing of the preserved biological materials using barrier technology.
대표청구항
▼
This invention relates to barrier methods for preserving sensitive biological materials as a porous foam, subsequently crushing the foam to form a powder, and optionally formulating mixtures of preserved powdered biological materials. The invention also encompasses an apparatus for integrating the m
This invention relates to barrier methods for preserving sensitive biological materials as a porous foam, subsequently crushing the foam to form a powder, and optionally formulating mixtures of preserved powdered biological materials. The invention also encompasses an apparatus for integrating the methods of foam formation and subsequent crushing of the preserved biological materials using barrier technology. 1; US-5698134, 19971200, Jubb et al., 252/299.01; US-5698343, 19971200, Sutherland et al., 430/001; US-5706375, 19980100, Mihailov et al., 385/024; US-5725970, 19980300, Martin et al., 430/002; US-5731853, 19980300, Taketomi et al., 349/015; US-5734485, 19980300, Buchkremer et al., 359/025; US-5748272, 19980500, Tanaka et al., 349/086; US-5751452, 19980500, Tanaka et al., 359/052; US-5771320, 19980600, Stone, 385/016; US-5832148, 19981100, Yariv, 385/016; US-5852504, 19981200, Kato et al., 359/009; US-5875012, 19990200, Crawford et al., 349/074; US-5915051, 19990600, Damask et al., 385/016; US-5930011, 19990700, Gambogi, Jr. et al., 359/015; US-5937115, 19990800, Domash, 385/016; US-5942157, 19990800, Sutherland et al., 252/582; US-6115152, 20000900, Popovich et al., 359/015; US-6172778, 20010100, Reinhorn et al., 359/015; US-6211976, 20010400, Popovich et al., 359/015
※ AI-Helper는 부적절한 답변을 할 수 있습니다.